| Financial Year |
March 31 2023 |
| Monetary Funds |
878,719,162.86 |
| Held-for-trading Financial Assets |
893,874,880.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,540,186,907.61 |
| Advances to Suppliers |
3,652,217.20 |
| Other Receivables |
4,007,556.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
732,671,999.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,238,225.20 |
| Total Current Assets |
4,704,592,145.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
21,889,327.07 |
| Fixed Assetes |
830,154,714.86 |
| Under-construction Projects |
291,556,520.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
58,035,185.04 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,200,991.74 |
| Deferred Income Tax Assets |
33,161,301.18 |
| Other Non-Current Assets |
13,574,448.20 |
| Sub-Total of Non-Current Assets |
1,316,465,115.98 |
| Total Assets |
6,021,057,261.25 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
435,550,000.00 |
| Accounts Payable |
2,043,183,902.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
82,621,729.85 |
| Taxes Payable |
48,042,610.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
43,255,867.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,355,811.48 |
| Other Current Liabilities |
325,388.27 |
| Sub-Total of Current Liabilities |
2,677,075,393.08 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
26,783,329.12 |
| Deferred Income Tax Liabilities |
39,131,614.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
168,887,263.21 |
| Total Liabilities |
2,845,962,656.29 |
| Paid-In Capital(Or Share Stock) |
435,599,919.00 |
| Capital Surplus |
1,716,969,879.43 |
| Surplus Reserve |
169,045,567.72 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
775,187,314.11 |
| Minority Stockholder's Interest |
44,538,098.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,130,556,506.04 |
| Owner's Equity（Stockholder's Equity） |
3,175,094,604.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,021,057,261.25 |
